Henry Schein (NASDAQ:HSIC) released its quarterly earnings results on Tuesday. The company reported $1.03 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.02, MarketWatch Earnings reports. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The firm had revenue of $3.28 billion for the quarter, compared to analyst estimates of $3.37 billion. During the same quarter last year, the company posted $0.87 earnings per share. The business’s revenue was up 3.8% on a year-over-year basis. Henry Schein updated its FY18 guidance to $4.06-4.14 EPS.
HSIC traded up $2.88 during trading on Wednesday, reaching $86.39. The company’s stock had a trading volume of 40,205 shares, compared to its average volume of 1,622,386. Henry Schein has a 52-week low of $62.56 and a 52-week high of $90.52. The firm has a market capitalization of $12.79 billion, a PE ratio of 24.06, a P/E/G ratio of 2.55 and a beta of 0.87. The company has a current ratio of 1.29, a quick ratio of 0.68 and a debt-to-equity ratio of 0.34.
A number of equities analysts recently issued reports on HSIC shares. BidaskClub raised Henry Schein from a “hold” rating to a “buy” rating in a report on Wednesday, August 22nd. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $85.00 price target on the stock in a report on Tuesday, July 10th. Leerink Swann set a $100.00 price target on Henry Schein and gave the stock a “buy” rating in a report on Tuesday, August 7th. Barrington Research reissued a “buy” rating and set a $92.00 price target on shares of Henry Schein in a report on Tuesday, August 7th. Finally, Craig Hallum raised their price target on Henry Schein from $83.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, August 7th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $83.53.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading: Return on Investment (ROI)
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.